---
up: 
down: 
related: 
tags: []
type:
  - "[[SUB.LO.C.PEX.ANZCA]]"
dg-publish: true
title: 7.3_CardiovascularPharmacology
date created: Wednesday, March 5th 2025, 20:50:23
date modified: Tuesday, March 25th 2025, 16:09:22
---

## 7.3 Cardiovascular System Pharmacology

This section covers the pharmacological agents affecting the cardiovascular system, including sympathomimetics, adrenergic blockers, antiarrhythmics, antihypertensives, and drugs used in the management of cardiac failure and ischemia.

### Learning Objectives

- [[ANZCA.7.3.1_BT_PO.1.52_Sympathomimetic_Anticholinergic_Drugs]]
- [[ANZCA.7.3.2_BT_PO.1.53_Adrenergic_Agonists]]
- [[ANZCA.7.3.3_BT_PO.1.54_Alpha_Beta_Receptor_Blockers]]
- [[ANZCA.7.3.4_BT_PO.1.55_Clinically_Important_Autonomic_Drug_Interactions]]
- [[ANZCA.7.3.5_BT_PO.1.56_Antiarrhythmic_Agents_Classification]]
- [[ANZCA.7.3.6_BT_PO.1.57_Amiodarone_Pharmacology_And_Others]]
- [[ANZCA.7.3.7_BT_PO.1.58_Glyceryl_Trinitrate_Sodium_Nitroprusside_And_Others]]
- [[ANZCA.7.3.8_BT_PO.1.59_Myocardial_Ischaemia_Infarction_Drugs]]
- [[ANZCA.7.3.9_BT_PO.1.60_Acute_Chronic_Cardiac_Failure_Drugs]]
- [[ANZCA.7.3.10_BT_RT.1.17_Vasopressors_Inotropes_Shock_Management]]
- [[ANZCA.7.3.11_BT_RT.1.18_ACLS_Drugs_Cardiopulmonary_Resuscitation]]
